QUOTED. Per Vegard Nerseth.
Executive Summary
CMR Surgical CEO Per Vegard Nerserth told Medtech Insight how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.
“My view is that we will probably see supply challenges throughout 2022 – this is a challenge we are going to have to live with.” – Per Vegard Nerserth, CEO, CMR Surgical
- > Find out more: Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS
Click here for a free trial of Medtech Insight